HYFT — MindWalk Holdings Corp.
—
Nasdaq ·
Health Care ·
Pharmaceuticals ·
CIK 1715925 ·
British Columbia, Canada
Last close
$1.50
Market Cap
$70.07M
52W High
$1.99
52W Low
$0.99
ADV30
475,275
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jan 2026 | 4,158,000 | 2,464,000 | -3,659,000 | -3,930,000 | 22,987,000 | 14,072,000 | 8,127,000 |
| Oct 2025 | 4,124,000 | 2,662,000 | -2,763,000 | -3,195,000 | 26,102,000 | 16,508,000 | 8,397,000 |
| Jul 2025 | 3,161,000 | 1,527,000 | -4,153,000 | -2,959,000 | 40,748,000 | 4,897,000 | 20,005,000 |
| Apr 2025 | 6,981,000 | 4,460,000 | -1,458,000 | -2,161,000 | 44,441,000 | 10,665,000 | 20,815,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-11,195,000
Investing CF
$13,197,000
Financing CF
$-18,000
CapEx
$-746,000
Dividends Paid
—
Buybacks
$-125,000
EPS Diluted TTM
$-0.88
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-138,864,000
Inventory
$490,000
Receivables
$3,009,000
ST Investments
$27,538,000
EBIT TTM
$-13,196,000
Pretax Income TTM
$-13,221,000
Interest Exp TTM
$185,000
Analysts
3
Yahoo Snapshot (yfinance, live)
Total Revenue
$28,084,000
EBITDA
$-10,485,000
Free Cash Flow
$-3,994,750
Enterprise Value
$62,461,568
Total Cash
$14,072,000
Total Debt
$3,524,000
Shares Out
46,711,866
Trailing EPS
$-0.10
Book Value
$0.23
ROE
-58.8%
ROA
-18.9%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Apr 2025 | 24,520,000 | -12,196,000 | -30,234,000 | 44,441,000 | 20,815,000 | — | -6,410,000 |
| Apr 2024 | 24,518,000 | -13,762,000 | -26,115,000 | 59,988,000 | 24,310,000 | — | -3,184,000 |
| Apr 2023 | 20,665,000 | -25,611,000 | -26,560,000 | 77,813,000 | 20,010,000 | — | -19,833,000 |
| Apr 2022 | 19,364,000 | -16,673,000 | -16,709,000 | 93,647,000 | 18,362,000 | — | -9,921,000 |
Max Pain — expiry 2026-08-21 (volume-derived — Yahoo OI feed degraded)
max pain strike: $2.50 · spot: $1.50 · call volume: 2 · put volume: 10
Expected Move to 2026-08-21:
±$1.13
(75.33%) —
implied range
$0.37 –
$2.63
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BGM | BGM Group Ltd. | $70.12M | $0.39 | — |
| CING | Cingulate Inc. | $68.96M | $5.12 | — |
| XBIT | XBiotech Inc. | $72.26M | $2.37 | — |
| PLRX | PLIANT THERAPEUTICS, INC. | $73.07M | $1.18 | — |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | $73.31M | $0.39 | — |
News headlines (Yahoo Finance, 1h cache)
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
2026-06-12 13:00 · Yahoo
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
2026-06-10 13:16 · Yahoo
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotype
2026-06-02 11:20 · Yahoo
The Biology Came First.
2026-05-18 12:34 · Yahoo
MindWalk Holdings Corp (HYFT) Q3 2026 Earnings Call Highlights: Revenue Surge and Strategic Shifts
2026-03-12 21:02 · Yahoo
MindWalk Holdings Corp. Q3 2026 Earnings Call Summary
2026-03-12 16:44 · Yahoo
MindWalk (HYFT) Q3 2026 Earnings Call Transcript
2026-03-12 16:39 · Yahoo
MindWalk Holdings Corp. (HYFT) Reports Q3 Loss, Lags Revenue Estimates
2026-03-12 13:45 · Yahoo
MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results
2026-03-12 12:31 · Yahoo
Stagwell (STGW) Q4 Earnings and Revenues Top Estimates
2026-03-10 13:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.